malignant pleural effusion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. meet the above diagnostic criteria; 2. Aged 20 ~ 70 years old; 3. X-ray or b-ultrasound showed malignant pleural effusion; 4. the survival time is expected to be more than 3 months; 5. ECOG PS score =3 months; 6. no chemotherapy or intrathoracic drug injection was given within 1 month before the inclusion of treatment; 7. participate in the study voluntarily and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. diagnosis of pleural effusion caused by unknown or simple hypoproteinemia; 2. routine blood tests showed that white blood cells were less than 3.5*109/L, hemoglobin was less than 80g/L, or platelets were less than 80*10^9/L; 3. severe pulmonary infection; 4. those with KPS score < 50 and estimated survival period < 3 months; 5. patients with abnormal fluid quality or multiple organ failure; 6. severe damage to the heart, liver or kidney or abnormal bone marrow function; 7. poor coagulation function, prone to massive bleeding; 8. patients with severe heart, brain, kidney and liver diseases; 9. patients cannot accept and tolerate fire needle therapy; 10. patients with mental problems who cannot cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom remission rate; | — |
Countries
China